Regulation of vascular smooth muscle cell dysfunction under diabetic conditions by MIR-504

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 36, Issue 5, 2016, Pages 864-873

  Reddy, Marpadga A ^a   Das, Sadhan ^a   Zhuo, Chen ^a   Jin, Wen ^a   Wang, Mei ^a   Lanting, Linda ^a   Natarajan, Rama ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

aorta; atherosclerosis; diabetes complications; inflammation; microRNAs; vascular smooth muscle cells

Indexed keywords

EARLY GROWTH RESPONSE FACTOR 2; FGF13 PROTEIN; GLUCOSE; GROWTH FACTOR; GROWTH FACTOR RECEPTOR BOUND PROTEIN 10; MICRORNA; MICRORNA 504; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PALMITIC ACID; PROTEIN INHIBITOR; SUPPRESSOR OF CYTOKINE SIGNALING 1; UNCLASSIFIED DRUG; EGR2 PROTEIN, MOUSE; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 13; GRB10 PROTEIN, MOUSE; MIRN504 MICRORNA, MOUSE; MITOGEN ACTIVATED PROTEIN KINASE; SOCS1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOINFORMATICS; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DIABETES MELLITUS; DOWN REGULATION; ENZYME ACTIVATION; GENE SILENCING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; REGULATORY MECHANISM; RNA SEQUENCE; SIGNAL TRANSDUCTION; UPREGULATION; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE CELL DYSFUNCTION; ANIMAL; AORTIC DISEASE; ATHEROSCLEROSIS; BIOLOGY; CELL CULTURE; CELL MOTION; DIABETIC ANGIOPATHY; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HIGH THROUGHPUT SEQUENCING; MALE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOLOGY; PHENOTYPE; PROCEDURES; RNA INTERFERENCE; SMOOTH MUSCLE CELL; THORACIC AORTA; VASCULAR SMOOTH MUSCLE;

ANIMALS; AORTA, THORACIC; AORTIC DISEASES; ATHEROSCLEROSIS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; COMPUTATIONAL BIOLOGY; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DISEASE MODELS, ANIMAL; EARLY GROWTH RESPONSE PROTEIN 2; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GLUCOSE; GRB10 ADAPTOR PROTEIN; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; MALE; MICRORNAS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PALMITIC ACID; PHENOTYPE; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SUPPRESSOR OF CYTOKINE SIGNALING 1 PROTEIN; TRANSFECTION;

EID: 84960156252     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.115.306770     Document Type: Article

References (73)

1. Ross R, The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993 362 801 809. doi: 10.1038/362801a0
2. Schwartz SM, Smooth muscle migration in atherosclerosis and restenosis. J Clin Invest 1997 100 11 Suppl S87 S89
3. Libby P, Inflammation in atherosclerosis. Nature 2002 420 868 874. doi: 10.1038/nature01323
4. Gomez D, Owens GK, Smooth muscle cell phenotypic switching in atherosclerosis. Cardiovasc Res 2012 95 156 164. doi: 10.1093/cvr/cvs115
5. Doran AC, Meller N, McNamara CA, Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler Thromb Vasc Biol 2008 28 812 819. doi: 10.1161/ATVBAHA.107.159327
6. Wall VZ, Bornfeldt KE, Arterial smooth muscle. Arterioscler Thromb Vasc Biol 2014 34 2175 2179. doi: 10.1161/ATVBAHA.114.304441
7. Natarajan R, Nadler JL, Lipid inflammatory mediators in diabetic vascular disease. Arterioscler Thromb Vasc Biol 2004 24 1542 1548. doi: 10.1161/01.ATV.0000133606.69732.4c
8. Natarajan R, Cai Q, Monocyte retention in the pathology of atherosclerosis. Future Cardiol 2005 1 331 340. doi: 10.1517/14796678.1.3.331
9. Rask-Madsen C, King GL, Proatherosclerotic mechanisms involving protein kinase C in diabetes and insulin resistance. Arterioscler Thromb Vasc Biol 2005 25 487 496. doi: 10.1161/01.ATV.0000155325.41507.e0
10. Allahverdian S, Chehroudi AC, McManus BM, Abraham T, Francis GA, Contribution of intimal smooth muscle cells to cholesterol accumulation and macrophage-like cells in human atherosclerosis. Circulation 2014 129 1551 1559. doi: 10.1161/CIRCULATIONAHA.113.005015
11. Schmidt AM, Yan SD, Wautier JL, Stern D, Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ Res 1999 84 489 497
12. Li SL, Reddy MA, Cai Q, Meng L, Yuan H, Lanting L, Natarajan R, Enhanced proatherogenic responses in macrophages and vascular smooth muscle cells derived from diabetic db/db mice. Diabetes 2006 55 2611 2619. doi: 10.2337/db06-0164
13. Meng L, Park J, Cai Q, Lanting L, Reddy MA, Natarajan R, Diabetic conditions promote binding of monocytes to vascular smooth muscle cells and their subsequent differentiation. Am J Physiol Heart Circ Physiol 2010 298 H736 H745. doi: 10.1152/ajpheart.00935.2009
14. Geraldes P, King GL, Activation of protein kinase C isoforms and its impact on diabetic complications. Circ Res 2010 106 1319 1331. doi: 10.1161/CIRCRESAHA.110.217117
15. Reddy MA, Li SL, Sahar S, Kim YS, Xu ZG, Lanting L, Natarajan R, Key role of Src kinase in S100B-induced activation of the receptor for advanced glycation end products in vascular smooth muscle cells. J Biol Chem 2006 281 13685 13693. doi: 10.1074/jbc.M511425200
16. Alexander MR, Owens GK, Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development and disease. Annu Rev Physiol 2012 74 13 40. doi: 10.1146/annurev-physiol-012110-142315
17. Albinsson S, Sessa WC, Can microRNAs control vascular smooth muscle phenotypic modulation and the response to injury? Physiol Genomics 2011 43 529 533. doi: 10.1152/physiolgenomics.00146.2010
18. Maegdefessel L, Rayner KJ, Leeper NJ, MicroRNA regulation of vascular smooth muscle function and phenotype: early career committee contribution. Arterioscler Thromb Vasc Biol 2015 35 2 6. doi: 10.1161/ATVBAHA.114.304877
19. Mendell JT, Olson EN, MicroRNAs in stress signaling and human disease. Cell 2012 148 1172 1187. doi: 10.1016/j.cell.2012.02.005
20. Urbich C, Kuehbacher A, Dimmeler S, Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc Res 2008 79 581 588. doi: 10.1093/cvr/cvn156
21. Albinsson S, Suarez Y, Skoura A, Offermanns S, Miano JM, Sessa WC, MicroRNAs are necessary for vascular smooth muscle growth, differentiation, and function. Arterioscler Thromb Vasc Biol 2010 30 1118 1126. doi: 10.1161/ATVBAHA.109.200873
22. Albinsson S, Skoura A, Yu J, DiLorenzo A, Fernández-Hernando C, Offermanns S, Miano JM, Sessa WC, Smooth muscle miRNAs are critical for post-natal regulation of blood pressure and vascular function. PLoS One 2011 6 e18869. doi: 10.1371/journal.pone.0018869
23. Wei Y, Schober A, Weber C, Pathogenic arterial remodeling: the good and bad of microRNAs. Am J Physiol Heart Circ Physiol 2013 304 H1050 H1059. doi: 10.1152/ajpheart.00267.2012
24. Zhou J, Li YS, Nguyen P, Wang KC, Weiss A, Kuo YC, Chiu JJ, Shyy JY, Chien S, Regulation of vascular smooth muscle cell turnover by endothelial cell-secreted microRNA-126: role of shear stress. Circ Res 2013 113 40 51. doi: 10.1161/CIRCRESAHA.113.280883
25. Ding Z, Wang X, Schnackenberg L, Khaidakov M, Liu S, Singla S, Dai Y, Mehta JL, Regulation of autophagy and apoptosis in response to ox-LDL in vascular smooth muscle cells, and the modulatory effects of the microRNA hsa-let-7 g. Int J Cardiol 2013 168 1378 1385. doi: 10.1016/j.ijcard.2012.12.045
26. Zhao J, Imbrie GA, Baur WE, Iyer LK, Aronovitz MJ, Kershaw TB, Haselmann GM, Lu Q, Karas RH, Estrogen receptor-mediated regulation of microRNA inhibits proliferation of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2013 33 257 265. doi: 10.1161/ATVBAHA.112.300200
27. Davis-Dusenbery BN, Chan MC, Reno KE, Weisman AS, Layne MD, Lagna G, Hata A, down-regulation of Kruppel-like factor-4 (KLF4) by microRNA-143/145 is critical for modulation of vascular smooth muscle cell phenotype by transforming growth factor-beta and bone morphogenetic protein 4. J Biol Chem 2011 286 28097 28110. doi: 10.1074/jbc.M111.236950
28. Jin W, Reddy MA, Chen Z, Putta S, Lanting L, Kato M, Park JT, Chandra M, Wang C, Tangirala RK, Natarajan R, Small RNA sequencing reveals microRNAs that modulate angiotensin II effects in vascular smooth muscle cells. J Biol Chem 2012 287 15672 15683. doi: 10.1074/jbc.M111.322669
29. Leung A, Trac C, Jin W, Lanting L, Akbany A, Sætrom P, Schones DE, Natarajan R, Novel long noncoding RNAs are regulated by angiotensin II in vascular smooth muscle cells. Circ Res 2013 113 266 278. doi: 10.1161/CIRCRESAHA.112.300849
30. Sun SG, Zheng B, Han M, Fang XM, Li HX, Miao SB, Su M, Han Y, Shi HJ, Wen JK, miR-146a and Krüppel-like factor 4 form a feedback loop to participate in vascular smooth muscle cell proliferation. EMBO Rep 2011 12 56 62. doi: 10.1038/embor.2010.172
31. Kato M, Castro NE, Natarajan R, MicroRNAs: potential mediators and biomarkers of diabetic complications. Free Radic Biol Med 2013 64 85 94. doi: 10.1016/j.freeradbiomed.2013.06.009
32. Reddy MA, Natarajan R, Epigenetic mechanisms in diabetic vascular complications. Cardiovasc Res 2011 90 421 429. doi: 10.1093/cvr/cvr024
33. Reddy MA, Jin W, Villeneuve L, Wang M, Lanting L, Todorov I, Kato M, Natarajan R, Pro-inflammatory role of microrna-200 in vascular smooth muscle cells from diabetic mice. Arterioscler Thromb Vasc Biol 2012 32 721 729. doi: 10.1161/ATVBAHA.111.241109
34. Villeneuve LM, Kato M, Reddy MA, Wang M, Lanting L, Natarajan R, Enhanced levels of microRNA-125b in vascular smooth muscle cells of diabetic db/db mice lead to increased inflammatory gene expression by targeting the histone methyltransferase Suv39h1. Diabetes 2010 59 2904 2915. doi: 10.2337/db10-0208
35. Chen TC, Sung ML, Kuo HC, Chien SJ, Yen CK, Chen CN, Differential regulation of human aortic smooth muscle cell proliferation by monocyte-derived macrophages from diabetic patients. PLoS One 2014 9 e113752. doi: 10.1371/journal.pone.0113752
36. Li T, Yang GM, Zhu Y, Wu Y, Chen XY, Lan D, Tian KL, Liu LM, Diabetes and hyperlipidemia induce dysfunction of VSMCs: contribution of the metabolic inflammation/miRNA pathway. Am J Physiol Endocrinol Metab 2015 308 E257 E269. doi: 10.1152/ajpendo.00348.2014
37. Xu J, Li L, Yun HF, Han YS, MiR-138 promotes smooth muscle cells proliferation and migration in db/db mice through down-regulation of SIRT1. Biochem Biophys Res Commun 2015 463 1159 1164. doi: 10.1016/j.bbrc.2015.06.076
38. Bazzoni F, Rossato M, Fabbri M, Gaudiosi D, Mirolo M, Mori L, Tamassia N, Mantovani A, Cassatella MA, Locati M, Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signals. Proc Natl Acad Sci U S A 2009 106 5282 5287. doi: 10.1073/pnas.0810909106
39. Villeneuve LM, Reddy MA, Lanting LL, Wang M, Meng L, Natarajan R, Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes. Proc Natl Acad Sci U S A 2008 105 9047 9052. doi: 10.1073/pnas.0803623105
40. Reddy MA, Zhang E, Natarajan R, Epigenetic mechanisms in diabetic complications and metabolic memory. Diabetologia 2015 58 443 455. doi: 10.1007/s00125-014-3462-y
41. Keating ST, El-Osta A, Epigenetics and metabolism. Circ Res 2015 116 715 736. doi: 10.1161/CIRCRESAHA.116.303936
42. Hu W, Chan CS, Wu R, Zhang C, Sun Y, Song JS, Tang LH, Levine AJ, Feng Z, Negative regulation of tumor suppressor p53 by microRNA miR-504. Mol Cell 2010 38 689 699. doi: 10.1016/j.molcel.2010.05.027
43. Kabir NN, Kazi JU, Grb10 is a dual regulator of receptor tyrosine kinase signaling. Mol Biol Rep 2014 41 1985 1992. doi: 10.1007/s11033-014-3046-4
44. Unoki M, Nakamura Y, Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway. Oncogene 2001 20 4457 4465. doi: 10.1038/sj.onc.1204608
45. Li S, Miao T, Sebastian M, Bhullar P, Ghaffari E, Liu M, Symonds AL, Wang P, The transcription factors Egr2 and Egr3 are essential for the control of inflammation and antigen-induced proliferation of B and T cells. Immunity 2012 37 685 696. doi: 10.1016/j.immuni.2012.08.001
46. Sumitomo S, Fujio K, Okamura T, Yamamoto K, Egr2 and Egr3 are the unique regulators for systemic autoimmunity. JAKSTAT 2013 2 e23952. doi: 10.4161/jkst.23952
47. Sobel BE, Acceleration of restenosis by diabetes: pathogenetic implications. Circulation 2001 103 1185 1187
48. Faries PL, Rohan DI, Takahara H, Wyers MC, Contreras MA, Quist WC, King GL, Logerfo FW, Human vascular smooth muscle cells of diabetic origin exhibit increased proliferation, adhesion, and migration. J Vasc Surg 2001 33 601 607. doi: 10.1067/mva.2001.111806
49. Hsueh WA, Jackson S, Law RE, Control of vascular cell proliferation and migration by PPAR-gamma: a new approach to the macrovascular complications of diabetes. Diabetes Care 2001 24 392 397
50. Wang CC, Gurevich I, Draznin B, Insulin affects vascular smooth muscle cell phenotype and migration via distinct signaling pathways. Diabetes 2003 52 2562 2569
51. Natarajan R, Reddy MA, Malik KU, Fatima S, Khan BV, Signaling mechanisms of nuclear factor-kappab-mediated activation of inflammatory genes by 13-hydroperoxyoctadecadienoic acid in cultured vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2001 21 1408 1413
52. Natarajan R, Gu JL, Rossi J, Gonzales N, Lanting L, Xu L, Nadler J, Elevated glucose and angiotensin II increase 12-lipoxygenase activity and expression in porcine aortic smooth muscle cells. Proc Natl Acad Sci U S A 1993 90 4947 4951
53. Desbuquois B, Carré N, Burnol AF, Regulation of insulin and type 1 insulin-like growth factor signaling and action by the Grb10/14 and SH2B1/B2 adaptor proteins. FEBS J 2013 280 794 816. doi: 10.1111/febs.12080
54. Lim MA, Riedel H, Liu F, Grb10: more than a simple adaptor protein. Front Biosci 2004 9 387 403
55. Holt LJ, Siddle K, Grb10 and Grb14: enigmatic regulators of insulin action-And more? Biochem J 2005 388 Pt 2 393 406. doi: 10.1042/BJ20050216
56. Morrione A, Valentinis B, Resnicoff M, Xu Sq, Baserga R, The role of mGrb10alpha in insulin-like growth factor I-mediated growth. J Biol Chem 1997 272 26382 26387
57. Dufresne AM, Smith RJ, The adapter protein GRB10 is an endogenous negative regulator of insulin-like growth factor signaling. Endocrinology 2005 146 4399 4409. doi: 10.1210/en.2005-0150
58. Giorgetti-Peraldi S, Murdaca J, Mas JC, Van Obberghen E, The adapter protein, Grb10, is a positive regulator of vascular endothelial growth factor signaling. Oncogene 2001 20 3959 3968. doi: 10.1038/sj.onc.1204520
59. Yu Y, Yoon SO, Poulogiannis G, Yang Q, Ma XM, Villén J, Kubica N, Hoffman GR, Cantley LC, Gygi SP, Blenis J, Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling. Science 2011 332 1322 1326. doi: 10.1126/science.1199484
60. Illert AL, Albers C, Kreutmair S, Leischner H, Peschel C, Miething C, Duyster J, Grb10 is involved in BCR-ABL-positive leukemia in mice. Leukemia 2015 29 858 868. doi: 10.1038/leu.2014.283
61. Mokbel N, Hoffman NJ, Girgis CM, Small L, Turner N, Daly RJ, Cooney GJ, Holt LJ, Grb10 deletion enhances muscle cell proliferation, differentiation and GLUT4 plasma membrane translocation. J Cell Physiol 2014 229 1753 1764. doi: 10.1002/jcp.24628
62. Liu B, Liu F, Feedback regulation of mTORC1 by Grb10 in metabolism and beyond. Cell Cycle 2014 13 2643 2644. doi: 10.4161/15384101.2014.954221
63. Kebache S, Ash J, Annis MG, Hagan J, Huber M, Hassard J, Stewart CL, Whiteway M, Nantel A, Grb10 and active Raf-1 kinase promote Bad-dependent cell survival. J Biol Chem 2007 282 21873 21883. doi: 10.1074/jbc.M611066200
64. Kawai-Kowase K, Owens GK, Multiple repressor pathways contribute to phenotypic switching of vascular smooth muscle cells. Am J Physiol Cell Physiol 2007 292 C59 C69. doi: 10.1152/ajpcell.00394.2006
65. Takahashi E, Berk BC, MAP kinases and vascular smooth muscle function. Acta Physiol Scand 1998 164 611 621
66. Natarajan R, Bai W, Rangarajan V, Gonzales N, Gu JL, Lanting L, Nadler JL, Platelet-derived growth factor BB mediated regulation of 12-lipoxygenase in porcine aortic smooth muscle cells. J Cell Physiol 1996 169 391 400. doi: 10.1002/(SICI)1097-4652(199611)169:2<391::AID-JCP19>3.0.CO;2-C
67. Natarajan R, Scott S, Bai W, Yerneni KK, Nadler J, Angiotensin II signaling in vascular smooth muscle cells under high glucose conditions. Hypertension 1999 33 1 Pt 2 378 384
68. Wilkinson DG, Bhatt S, Chavrier P, Bravo R, Charnay P, Segment-specific expression of a zinc-finger gene in the developing nervous system of the mouse. Nature 1989 337 461 464. doi: 10.1038/337461a0
69. Laslo P, Spooner CJ, Warmflash A, Lancki DW, Lee HJ, Sciammas R, Gantner BN, Dinner AR, Singh H, Multilineage transcriptional priming and determination of alternate hematopoietic cell fates. Cell 2006 126 755 766. doi: 10.1016/j.cell.2006.06.052
70. Pospisil V, Vargova K, Kokavec J, Rybarova J, Savvulidi F, Jonasova A, Necas E, Zavadil J, Laslo P, Stopka T, Epigenetic silencing of the oncogenic miR-17-92 cluster during PU.1-directed macrophage differentiation. EMBO J 2011 30 4450 4464. doi: 10.1038/emboj.2011.317
71. Pham TH, Benner C, Lichtinger M, Schwarzfischer L, Hu Y, Andreesen R, Chen W, Rehli M, Dynamic epigenetic enhancer signatures reveal key transcription factors associated with monocytic differentiation states. Blood 2012 119 e161 e171. doi: 10.1182/blood-2012-01-402453
72. Lemaire P, Revelant O, Bravo R, Charnay P, Two mouse genes encoding potential transcription factors with identical DNA-binding domains are activated by growth factors in cultured cells. Proc Natl Acad Sci U S A 1988 85 4691 4695
73. Shen H, Eguchi K, Kono N, Fujiu K, Matsumoto S, Shibata M, Oishi-Tanaka Y, Komuro I, Arai H, Nagai R, Manabe I, Saturated fatty acid palmitate aggravates neointima formation by promoting smooth muscle phenotypic modulation. Arterioscler Thromb Vasc Biol 2013 33 2596 2607. doi: 10.1161/ATVBAHA.113.302099